Republic of Moldova vs Serbia: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Republic of Moldova
85.0%
in 2024
Serbia
85.0%
in 2024
Republic of Moldova rank
88th
Serbia rank
88th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Republic of Moldova
- Serbia
How they compare
Republic of Moldova currently reports 85.0% against 85.0% in Serbia, a difference of 0.0%.
The two have swapped places 3 times across 7 shared years of data; in 2018 it was Republic of Moldova ahead.
Republic of Moldova ranks 88th and Serbia ranks 88th of 146 countries.
Across the 2 decades both report, Republic of Moldova averaged higher in 1 and Serbia in 1.
Head to head by decade
| Decade | Republic of Moldova | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 82.5% | 79.5% | 3.0% | Republic of Moldova |
| 2020s | 79.8% | 86.8% | 7.0% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Republic of Moldova or Serbia?
- Republic of Moldova, at 85.0% against 85.0% in Serbia as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Republic of Moldova and Serbia?
- 0.0%, with Republic of Moldova ahead.
- How many years of comparable data are there for Republic of Moldova and Serbia?
- 7 years are reported by both, from 2018 to 2024.
- How do Republic of Moldova and Serbia rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Republic of Moldova ranks 88th and Serbia ranks 88th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.